1. Home
  2. TYRA

TYRA

Tyra Biosciences Inc.

Logo Tyra Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 3:30pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

Founded: 2018 Country:
N/A
Employees: N/A City: CARLSBAD
Market Cap: 786.8M IPO Year: 2021
Target Price: $25.33 AVG Volume (30 days): 141.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.62 EPS Growth: N/A
52 Week Low/High: $10.38 - $20.67 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of Tyra Biosciences Inc. (TYRA)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Bensen Daniel TYRA Chief Operating Officer Mar 1 '24 Sell $20.04 2,900 $58,111.94 439,936 SEC Form 4
Bensen Daniel TYRA Chief Operating Officer Mar 1 '24 Sell $20.08 5,063 $101,653.90 434,873 SEC Form 4
Bensen Daniel TYRA Chief Operating Officer Mar 1 '24 Sell $20.02 1,189 $23,802.47 433,684 SEC Form 4
Bensen Daniel TYRA Chief Operating Officer Feb 12 '24 Sell $20.00 1,501 $30,020.00 451,480 SEC Form 4
Harris Todd TYRA President and CEO Feb 2 '24 Sell $16.45 78,996 $1,299,160.32 1,523,701 SEC Form 4
Harris Todd TYRA President and CEO Feb 2 '24 Sell $17.04 7,187 $122,494.51 1,516,514 SEC Form 4
Harris Todd TYRA President and CEO Feb 2 '24 Sell $16.97 13,817 $234,430.28 1,502,697 SEC Form 4